I have discussed Fossil Group (FOSL) previously, so investors should view this as an update to my earlier coverage of the company. It's been a wild ride for shareholders of lifestyle accessories giant ...

A nonprofit recently reported that, since 2009, the National Institutes of Health and many of its scientists received an estimated $350 million in royalties for developing experimental treatments.

A case pending in the Ninth Circuit Court of Appeals highlights the importance of negotiating the term of royalty payments in the license of Food and Drug Administration (FDA)-regulated products. This ...